| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.058 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.053 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |